SCHEMBL3589932

SCHEMBL3589932

O=C(Cn1c(Cl)nc2ccccc21)NCCNCC1CCCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HTT P42858 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
POLB P06746 1/20 0.44
ALOX15 P16050 1/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
TSHR P16473 3/20 0.43
KDM4E B2RXH2 1/20 0.43
MAPT P10636 1/20 0.43
MEN1 O00255 1/20 0.42
PKM P14618 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
BACE1 P56817 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC10 Q969S8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3598193 0.87 LMNA (0.57) LMNAHDAC6HTTL3MBTL1ALDH1A1
SCHEMBL3587773 0.85 ALDH1A1 (0.50) HDAC6HTTL3MBTL1POLBALDH1A1
SCHEMBL3608186 0.85 KDM4E (0.54) LMNAHDAC6HTTALDH1A1TSHR
SCHEMBL3596889 0.85 HTT (0.66) LMNAHDAC6HTTL3MBTL1ALDH1A1
SCHEMBL3595689 0.85 ALDH1A1 (0.51) LMNAHDAC6HTTL3MBTL1POLB
SCHEMBL3610556 0.82 KDM4E (0.62) HTTL3MBTL1ALDH1A1TSHRKDM4E
SCHEMBL3599795 0.81 HDAC6 (0.47) HDAC6L3MBTL1POLBALOX15ALDH1A1
SCHEMBL3589935 0.81 LMNA (0.50) LMNAHTTL3MBTL1ALDH1A1GAA
SCHEMBL3600244 0.78 GAA (0.58) HTTPOLBALOX15ALDH1A1GAA
SCHEMBL3591235 0.78 LMNA (0.39) LMNAHDAC6HTTPOLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807704-B2 Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2 CHEMOCENTRYX, INC. (US) 2010-10-05 US disclosed
US-20070275965-A1 CXCR4 modulators CHEMOCENTRYX, INC. (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070275965-A1 CXCR4 modulators CXCL12, CXCR4, CXCR1 LMNA 4638/4885HDAC6 1799/4885HTT 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.